Boston Trust Walden’s Morningstar MORN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-916
Closed -$250K 381
2022
Q1
$250K Buy
+916
New +$259K ﹤0.01% 364
2021
Q1
Sell
-124,865
Closed -$28.9M 375
2020
Q4
$28.9M Sell
124,865
-37,628
-23% -$7.47M 0.31% 115
2020
Q3
$26.1M Buy
162,493
+7,197
+5% +$1.14M 0.33% 104
2020
Q2
$21.9M Buy
155,296
+12,624
+9% +$1.78M 0.3% 108
2020
Q1
$16.6M Buy
142,672
+4,075
+3% +$590K 0.26% 119
2019
Q4
$21M Buy
138,597
+2,798
+2% +$430K 0.24% 127
2019
Q3
$19.8M Buy
135,799
+662
+0.5% +$102K 0.25% 120
2019
Q2
$19.5M Sell
135,137
-1,683
-1% -$232K 0.25% 117
2019
Q1
$17.2M Buy
136,820
+874
+0.6% +$105K 0.23% 125
2018
Q4
$14.9M Sell
135,946
-30,241
-18% -$3.54M 0.24% 121
2018
Q3
$20.9M Sell
166,187
-50,345
-23% -$6.79M 0.29% 108
2018
Q2
$27.8M Sell
216,532
-5,355
-2% -$612K 0.41% 78
2018
Q1
$21.2M Sell
221,887
-14,153
-6% -$1.36M 0.32% 96
2017
Q4
$22.9M Sell
236,040
-1,839
-0.8% -$166K 0.34% 96
2017
Q3
$20.2M Buy
237,879
+967
+0.4% +$78.8K 0.31% 98
2017
Q2
$18.6M Buy
236,912
+55,347
+30% +$4.18M 0.3% 112
2017
Q1
$14.3M Sell
181,565
-17,297
-9% -$1.35M 0.22% 146
2016
Q4
$14.6M Buy
+198,862
New +$14.6M 0.23% 151

Other funds holding MORN

Boston Trust Walden's MORN Position: Q2 2022 in Review

Boston Trust Walden sold out of Morningstar (MORN) in Q2 2022, closing a stake of 916 shares — an estimated $250K sold.

Boston Trust Walden first reported a position in MORN in Q4 2016 and held it in 18 quarters. The position peaked at $28.9M in Q4 2020. 324 funds tracked by Wall St. Rank hold MORN as of Q2 2022.

  • Boston Trust Walden reported no remaining Morningstar position as of Q2 2022 after selling out during the quarter.
  • Boston Trust Walden sold 916 Morningstar shares in Q2 2022, an estimated $250K.
  • Boston Trust Walden first reported a position in Morningstar in Q4 2016 and held it in 18 quarters.
  • Boston Trust Walden's Morningstar position peaked at $28.9M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Morningstar as of Q2 2022.

Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.